ONIX Life Sciences
ONIX Life Sciences is a privately held, micro-cap pharmaceutical services firm (1–10 employees, founded 2010, Berkshire, United States) that provides eCTD Submission Services to pharmaceutical companies for regulatory filings with health authorities.
- Company typePrivate
- Founded2010
- HeadquartersBerkshire, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What ONIX Life Sciences does
ONIX Life Sciences is a privately held, micro-cap pharmaceutical services firm founded in 2010 and based in Berkshire, United States. According to available firmographic data, the company offers eCTD (electronic Common Technical Document) Submission Services to the pharmaceutical industry, positioning it as a specialist in the preparation and electronic filing of regulatory dossiers for health authorities such as the U.S. FDA. With a stated headcount of 1–10 employees, the company operates as a boutique service provider rather than a scaled platform business.
The company's offering centers on eCTD submission services — a specialized regulatory workflow that requires familiarity with the ICH eCTD specification, document granularity requirements, and the technical validation expectations of regulators. No proprietary technology stack, software platform, automation tooling, or differentiated methodology is disclosed in the source data, which suggests service delivery is most likely labor-based (manual compilation, formatting, validation, and submission of regulatory dossiers) rather than technology-mediated. No pricing model, customer references, partnership ecosystem, certifications, awards, or patent portfolio is documented.
The business model appears to be fee-for-service regulatory submission support, but no pricing structure, contract terms, customer profile, or revenue mechanics are disclosed. No funding history, investor base, ownership structure, or financial details are available in the input data. The company's website (onixls.com) was inaccessible at the time of data capture, displaying only a verification/loader page, which limits corroboration of any product, customer, or operational claim. The overall evidence base is thin, and most investment-relevant attributes — including revenue, customer base, competitive positioning, and growth trajectory — cannot be verified from the available input.
ONIX Life Sciences firmographics
Firmographics- Name
- ONIX Life Sciences
- Website
- https://onixls.com
- Company type
- Private
- Founded year
- 2010
- Headcount range
- 1–10 employees
- Short description
- ONIX Life Sciences is a privately held, micro-cap pharmaceutical services firm (1–10 employees, founded 2010, Berkshire, United States) that provides eCTD Submission Services to pharmaceutical companies for regulatory filings with health authorities.
- Ownership category
- akta.pro rank
ONIX Life Sciences industry classification
Industry- Product category
- Pharmaceutical Regulatory Services
- NAICS
- Other Scientific and Technical Consulting Services (54169), Document Preparation Services (56141)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC)
- akta.pro secondary industries
- Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Regulatory Submissions & Clinical Content Management (eCTD/Publishing) (HLACAOAN)
Keywords
Where ONIX Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Berkshire
- HQ country
- United States
- HQ region
- North America
Markets served
ONIX Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations
ONIX Life Sciences product offering
Product offeringCore offering
ONIX Life Sciences provides eCTD (electronic Common Technical Document) submission services to pharmaceutical companies, supporting regulatory submission preparation and filing for drug approval processes. The firm operates as a small, specialized service provider focused on helping pharmaceutical clients compile and submit regulatory dossiers in the eCTD format required by health authorities.
Differentiator
Problem solved
Functional benefit
Companies that use ONIX Life Sciences
Customer profileIdeal customer profiles1 record
ONIX Life Sciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ONIX Life Sciences competitors and assessment
Company assessmentEmerging players
- MakroCare: MakroCare provides global regulatory affairs and eCTD submission services to life sciences clients. It overlaps with ONIX on submission publishing and extends into regulatory strategy, making it a directly comparable peer.
- ProPharma Group: ProPharma offers regulatory affairs consulting, medical writing, and submission support to pharma/biotech. It is comparable as a mid-sized regulatory services provider with overlapping eCTD and submission management work.
Broad incumbents
- Veeva Systems: Veeva's Vault RIM and Submissions suite provides software for eCTD publishing, submission management, and document management, competing with ONIX on the enabling layer and increasingly on managed services.
- ICON plc: ICON provides global regulatory consulting and submission services (including eCTD publishing) through its regulatory affairs group. It is a broad incumbent that overlaps with ONIX on large multi-region submission programs.
- Parexel International: Parexel is one of the largest CROs and offers comprehensive regulatory affairs and eCTD publishing services alongside clinical and post-approval offerings. It competes with ONIX on submission services as part of a much broader portfolio.
- IQVIA: IQVIA is the largest CRO and includes regulatory operations and eCTD publishing capabilities inside its technology-enabled services portfolio. It competes with smaller eCTD specialists via scale and integrated deals.
- DXC Technology (formerly CSC Life Sciences): DXC (via its CSC heritage) offers regulatory information management and eCTD/eSubmission services as part of its life sciences practice. It competes with ONIX on managed regulatory services for large sponsors.
Direct peers
- Freyr Solutions: Freyr is a dedicated regulatory services and eCTD publishing specialist serving pharma and biotech sponsors globally. It directly competes with ONIX by offering submission publishing, regulatory operations, and global submission management as a focused service.
- C3i Solutions (now Odins): C3i (Odins) provides eCTD publishing, RIM implementation, and regulatory operations outsourcing to life sciences sponsors. It overlaps directly with ONIX's submission publishing offering and target customer base.
- Lifepoint Group (incl. Lorenz Life Sciences): Lifepoint/Lorenz provides eCTD submission software and managed regulatory publishing services. It directly competes with ONIX in the eCTD publishing and submission management niche.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
ONIX Life Sciences social profiles
Digital presenceONIX Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
ONIX Life Sciences leadership team
Management profileNumber of profiles
ONIX Life Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ONIX Life Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ONIX Life Sciences
What does ONIX Life Sciences do?
ONIX Life Sciences provides eCTD (electronic Common Technical Document) submission services to pharmaceutical companies, supporting regulatory submission preparation and filing for drug approval processes. The firm operates as a small, specialized service provider focused on helping pharmaceutical clients compile and submit regulatory dossiers in the eCTD format required by health authorities.
When was ONIX Life Sciences founded?
ONIX Life Sciences was founded in 2010. It employs 1 to 10 people.
Where is ONIX Life Sciences based?
ONIX Life Sciences is headquartered in Berkshire, United States, in the North America region.
Who are ONIX Life Sciences's main competitors?
Emerging players on record are MakroCare and ProPharma Group. Broad incumbents are Veeva Systems, ICON plc, Parexel International, IQVIA and DXC Technology (formerly CSC Life Sciences). Direct peers are Freyr Solutions, C3i Solutions (now Odins) and Lifepoint Group (incl. Lorenz Life Sciences).
Does ONIX Life Sciences have an API?
No public API is recorded for ONIX Life Sciences.
What industry is ONIX Life Sciences in?
ONIX Life Sciences's product category is Pharmaceutical Regulatory Services. Its primary akta.pro industry code is HLAGAKAC, Regulatory Operations & Publishing (eCTD, RIM, Submission Management), with a secondary code of HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA). Its NAICS code is 54169 and its SIC code is 8731.